Which federal law mandates the creation of a national drug monitoring program?

Which federal law mandates the creation of a national drug monitoring program?

• A. Controlled Substances Act
• B. Drug Quality and Security Act
• C. Comprehensive Addiction and Recovery Act
• D. Food, Drug, and Cosmetic Act

Answer: (C)

The Comprehensive Addiction and Recovery Act (CARA) is the federal law that mandates the creation of a national drug monitoring program. This legislation, enacted in 2016, was a response to the growing opioid epidemic and aimed to improve prevention, treatment, and recovery services for individuals suffering from addiction. One of the key provisions of CARA was the establishment of a national strategy to monitor prescription drug use, which includes the use of prescription drug monitoring programs (PDMPs) to track prescriptions and prevent misuse and abuse of controlled substances. CARA emphasizes the need for enhanced communication and interoperability between state PDMPs, allowing for better tracking of prescription medications across state lines. This is crucial for identifying and addressing patterns of prescription drug abuse, including overprescribing and doctor shopping, which are significant issues in the realm of substance use disorder. While the other laws mentioned have important roles in the regulation of drugs and addressing drug-related issues, they do not specifically mandate the creation of a national drug monitoring program. The Controlled Substances Act primarily governs the handling of controlled substances, the Drug Quality and Security Act focuses on the quality and security of the drug supply chain, and the Food, Drug, and Cosmetic Act pertains to the safety and efficacy of drugs and food but

The Comprehensive Addiction and Recovery Act (CARA) is the federal law that mandates the creation of a national drug monitoring program. This legislation, enacted in 2016, was a response to the growing opioid epidemic and aimed to improve prevention, treatment, and recovery services for individuals suffering from addiction. One of the key provisions of CARA was the establishment of a national strategy to monitor prescription drug use, which includes the use of prescription drug monitoring programs (PDMPs) to track prescriptions and prevent misuse and abuse of controlled substances.

CARA emphasizes the need for enhanced communication and interoperability between state PDMPs, allowing for better tracking of prescription medications across state lines. This is crucial for identifying and addressing patterns of prescription drug abuse, including overprescribing and doctor shopping, which are significant issues in the realm of substance use disorder.

While the other laws mentioned have important roles in the regulation of drugs and addressing drug-related issues, they do not specifically mandate the creation of a national drug monitoring program. The Controlled Substances Act primarily governs the handling of controlled substances, the Drug Quality and Security Act focuses on the quality and security of the drug supply chain, and the Food, Drug, and Cosmetic Act pertains to the safety and efficacy of drugs and food but